135 related articles for article (PubMed ID: 29552305)
1.
Kanwal M; Ding XJ; Song X; Zhou GB; Cao Y
Oncotarget; 2018 Feb; 9(15):12226-12239. PubMed ID: 29552305
[TBL] [Abstract][Full Text] [Related]
2.
Chen Y; Huang Y; Kanwal M; Li G; Yang J; Niu H; Li Z; Ding X
Transl Lung Cancer Res; 2019 Aug; 8(4):476-488. PubMed ID: 31555520
[TBL] [Abstract][Full Text] [Related]
3. Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study.
Jiang CL; He SW; Zhang YD; Duan HX; Huang T; Huang YC; Li GF; Wang P; Ma LJ; Zhou GB; Cao Y
Oncotarget; 2017 Jan; 8(1):1369-1391. PubMed ID: 27901495
[TBL] [Abstract][Full Text] [Related]
4. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells.
Reinartz S; Failer S; Schuell T; Wagner U
Eur J Cancer; 2012 Jul; 48(10):1558-69. PubMed ID: 21852110
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells.
Huang Y; Huang X; Zeng J; Lin J
Front Oncol; 2021; 11():667669. PubMed ID: 34150633
[TBL] [Abstract][Full Text] [Related]
6. MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment.
Hu J; Sun J
Oncoimmunology; 2018; 7(10):e1487914. PubMed ID: 30288353
[TBL] [Abstract][Full Text] [Related]
7. The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity.
Saad HM; Tourky GF; Al-Kuraishy HM; Al-Gareeb AI; Khattab AM; Elmasry SA; Alsayegh AA; Hakami ZH; Alsulimani A; Sabatier JM; Eid MW; Shaheen HM; Mohammed AA; Batiha GE; De Waard M
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552994
[TBL] [Abstract][Full Text] [Related]
8. Why
Huang YJ; Cao ZF; Wang J; Yang J; Wei YJ; Tang YC; Cheng YX; Zhou J; Zhang ZX
World J Clin Cases; 2021 Jun; 9(17):4143-4158. PubMed ID: 34141777
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
Liu L; Xiang J; Chen R; Fu D; Hong D; Hao J; Li Y; Li J; Li S; Mou Y; Mai G; Ni Q; Peng L; Qin R; Qian H; Shao C; Sun B; Sun Y; Tao M; Tian B; Wang H; Wang J; Wang L; Wang W; Wang W; Zhang J; Zhao G; Zhou J; Yu X;
Int J Oncol; 2016 Mar; 48(3):900-7. PubMed ID: 26718269
[TBL] [Abstract][Full Text] [Related]
10. Characterization of germline mutations in familial lung cancer from the Chinese population.
Kanwal M; Ding XJ; Ma ZH; Li LW; Wang P; Chen Y; Huang YC; Cao Y
Gene; 2018 Jan; 641():94-104. PubMed ID: 29054765
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.
Morgado M; Sutton MN; Simmons M; Warren CR; Lu Z; Constantinou PE; Liu J; Francis LL; Conlan RS; Bast RC; Carson DD
Oncotarget; 2016 Mar; 7(12):14871-84. PubMed ID: 26918940
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
Wang H; Yan C; Ye H
Exp Ther Med; 2020 Aug; 20(2):1725-1733. PubMed ID: 32765681
[TBL] [Abstract][Full Text] [Related]
13. Investigation of radon and heavy metals in Xuanwei and Fuyuan, high lung cancer incidence areas in China.
Lv J; Zhang W; Xu R
J Environ Health; 2013 Nov; 76(4):32-8. PubMed ID: 24341159
[TBL] [Abstract][Full Text] [Related]
14. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.
Boivin M; Lane D; Piché A; Rancourt C
Gynecol Oncol; 2009 Dec; 115(3):407-13. PubMed ID: 19747716
[TBL] [Abstract][Full Text] [Related]
15. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.
White NM; Mathews M; Yousef GM; Prizada A; Fontaine D; Ghatage P; Popadiuk C; Dawson L; Doré JJ
Cancer Biomark; 2009; 5(6):279-87. PubMed ID: 20037204
[TBL] [Abstract][Full Text] [Related]
16. CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.
Akita K; Tanaka M; Tanida S; Mori Y; Toda M; Nakada H
Eur J Cell Biol; 2013; 92(8-9):257-63. PubMed ID: 24246580
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy.
Das S; Batra SK
Cancer Res; 2015 Nov; 75(22):4669-74. PubMed ID: 26527287
[TBL] [Abstract][Full Text] [Related]
18. Indoor and outdoor air pollution of polycyclic aromatic hydrocarbons (PAHs) in Xuanwei and Fuyuan, China.
Lv J; Xu R; Wu G; Zhang Q; Li Y; Wang P; Liao C; Liu J; Jiang G; Wei F
J Environ Monit; 2009 Jul; 11(7):1368-74. PubMed ID: 20449226
[TBL] [Abstract][Full Text] [Related]
19. Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane.
Su Y; Tatzel K; Wang X; Belt B; Binder P; Kuroki L; Powell MA; Mutch DG; Hawkins WG; Spitzer D
Oncotarget; 2016 May; 7(21):31534-49. PubMed ID: 27120790
[TBL] [Abstract][Full Text] [Related]
20. Sequencing Analysis of
Gaździcka J; Biernacki K; Salatino S; Gołąbek K; Hudy D; Świętek A; Miśkiewicz-Orczyk K; Koniewska A; Misiołek M; Strzelczyk JK
Curr Issues Mol Biol; 2023 Jul; 45(7):5645-5661. PubMed ID: 37504272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
